SCHEMBL19626686

SCHEMBL19626686

Cc1nc(-c2ccc(NC(=O)Cn3cnc4c3C(=O)N(C)C(O)N4C)cc2)cs1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 13/20 0.52
▸ NPC1 O15118 12/20 0.52
▸ SMN1; SMN2 Q16637 6/20 0.52
▸ ALDH1A1 P00352 5/20 0.48
▸ GFER P55789 1/20 0.48
▸ MEN1 O00255 4/20 0.48
▸ KMT2A Q03164 4/20 0.48
▸ HPGD P15428 2/20 0.48
▸ LMNA P02545 1/20 0.48
▸ TRPA1 O75762 2/20 0.47
▸ TRPV4 Q9HBA0 1/20 0.46
▸ KDM4E B2RXH2 3/20 0.43
▸ MAPT P10636 2/20 0.43
▸ NFKB1 P19838 2/20 0.43
▸ NFKB2 Q00653 2/20 0.43
▸ RELA Q04206 2/20 0.43
▸ STAT1 P42224 2/20 0.43
▸ MAPK1 P28482 1/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21935695 0.84 PORCN (0.46) SMN1; SMN2TRPA1TRPV4RXFP1TP53
SCHEMBL19997382 0.82 PORCN (0.40) SMN1; SMN2ALDH1A1MEN1KMT2ALMNA
SCHEMBL22105263 0.82 PORCN (0.40) SMN1; SMN2ALDH1A1MEN1KMT2ALMNA
SCHEMBL20029975 0.81 MEN1 (0.48) SMN1; SMN2ALDH1A1MEN1KMT2ATRPA1
SCHEMBL19626687 0.81 SMN1; SMN2 (0.42) RAB9ANPC1SMN1; SMN2ALDH1A1MEN1
SCHEMBL22105261 0.80 PSEN1 (0.41) RAB9ANPC1SMN1; SMN2ALDH1A1MEN1
SCHEMBL19626637 0.79 PORCN (0.51) —
SCHEMBL19590909 0.79 KMT2A (0.47) SMN1; SMN2ALDH1A1MEN1KMT2AHPGD
SCHEMBL19590905 0.78 TRPA1 (0.41) SMN1; SMN2ALDH1A1MEN1KMT2ALMNA
SCHEMBL19626536 0.78 MAPT (0.47) SMN1; SMN2ALDH1A1MEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2999699-B1 PURINE DIONES AS WNT PATHWAY MODULATORS AGENCY SCIENCE TECH & RES (SG) 2020-04-29 — — EP disclosed
US-10472360-B2 Purine diones as Wnt pathway modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2019-11-12 — — US disclosed
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators WNT1, WNT3A, CTNNB1 RAB9A 3162/4885NPC1 2489/4885SMN1; SMN2 4828/4885
US-10472360-B2 Purine diones as Wnt pathway modulators WNT1, WNT3A, CTNNB1 RAB9A 3162/4885NPC1 2489/4885SMN1; SMN2 4828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback